Presolicitation
Morphine Sulfate Solution
Dept of Defense · Defense Logistics Agency · Sol. SPE2D2-26-R-0017
No deadline
AI summary Beta
The Defense Logistics Agency plans to buy morphine sulfate injection syringes and vials through a national requirements contract with a one-year base and four one-year options. Only domestic manufacturers of both the active ingredient and the finished product can compete. This is an advance notice; the solicitation is expected around October or November 2026.
Watch out for
- Domestic manufacturing only. Resellers and companies using imported ingredients or finished product cannot compete, which rules out most small businesses.
the procurement will be competed among all qualified domestic manufacturers
- Controlled substance. Morphine is a controlled drug, so the maker would need the related licensing, though the notice does not list specifics.
- Solicitation date not firm. DLA may issue the solicitation earlier or later than projected.
DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Read from the notice text only.
Full brief
What they want
- Morphine Sulfate 2MG/ML and 4MG/ML Injection Syringe and 2MG/ML and 10MG/ML Intravenous Syringe, packs of 10
- Morphine Sulfate 2MG/ML, 4MG/ML and 10MG/ML Injection Solution Vial and 4MG/ML and 10MG/ML Intravenous Solution Vial, boxes of 25
- Supply to DoW, VA, Indian Health Service and Bureau of Prisons customers through DLA and VA prime vendor programs
- Contract type
- Firm-fixed-price requirements contract (FAR 52.216-21), commercial item under FAR Part 12
- Period of performance
- One-year base plus four one-year options
- Contract vehicle
- DLA and VA prime vendor programs (customers buy through them)
- How to submit
- Solicitation will be posted to DLA Bid Board System (DIBBS) and SAM.gov
What to include when you submit
- Projected solicitation date is October/November 2026
- Set up automated notifications for pre-solicitation or solicitation changes
You must have
- Domestic manufacturer of both the active pharmaceutical ingredient and the final dosage form
Competition will be restricted to domestic sources (vendors providing Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) manufactured domestically)
Not in the notice text
- Annual usage estimates (to come in the solicitation Schedule of Supplies)
- Evaluation method and factors
- Offer due date
- Specific licensing or FDA requirements
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Creating an account is free.
Key facts
- Posted
- Sep 21, 2026
- Notice type
- Presolicitation
- Solicitation
- SPE2D2-26-R-0017
- Agency
- Dept of Defense · Defense Logistics Agency
- Office
- DLA Troop Support
- NAICS
- 325412
- Product/service code
- 6505
- Business type
- Medical & healthcare
- Contracting contact
- Christopher Newmanchristopher.newman@dla.mil4457377371
Full notice text from SAM.gov
The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Morphine Sulfate Solution. Procurement details follow. Morphine Sulfate 2MG/ML and 4MG/ML Injection Syringe and 2MG/ML and 10MG/ML Intravenous Syringe in Packs of 10. Morphine Sulfate 2MG/ML, 4MG/ML, and 10MG/ML Injection Solution Vial and 4MG/ML and 10MG/ML Intravenous Solution Vial in Boxes of 25. Competition will be restricted to domestic sources (vendors providing Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) manufactured domestically), the procurement will be competed among all qualified domestic manufacturers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War (DoW), Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Christopher Newman at (445) 737-7371 or Christopher.Nemwan@dla.mil with any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is October/November of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar open opportunities
- Latanoprost Ophthalmic Solution (VA-27-00006027)The VA Enterprise Procurement Office plans an unrestricted RFP for Latanoprost eye drops for the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health Care Center.
- Imatinib TabletsThe VA Enterprise Procurement Office plans an unrestricted RFP for Imatinib Mesylate tablets to supply the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health…
- Methylphenidate ERThe Defense Logistics Agency (DLA Troop Support) plans a national requirements contract for Methylphenidate ER tablets (18, 27, 36 and 54 mg, 100-count bottles).
- Epinephrine InjectorThe Defense Logistics Agency (DLA Troop Support) is soliciting a national requirements contract for epinephrine 0.3 mg auto-injectors, to supply Department of Defense, VA, Indian…
- Prednisolone 1% Ophthalmic Solution